| Primary |
| Atrial Fibrillation |
66.6% |
| Thrombosis Prophylaxis |
5.5% |
| Cerebrovascular Accident Prophylaxis |
4.0% |
| Hypertension |
4.0% |
| Pain |
3.6% |
| Cerebrovascular Accident |
2.2% |
| Atrial Flutter |
2.0% |
| Prophylaxis |
1.4% |
| Blood Pressure |
1.2% |
| Cardiac Failure |
1.2% |
| Deep Vein Thrombosis |
1.2% |
| Heart Rate Irregular |
1.0% |
| Asthma |
0.8% |
| Pulmonary Embolism |
0.8% |
| Thrombosis |
0.8% |
| Transient Ischaemic Attack |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Analgesic Therapy |
0.6% |
| Arrhythmia |
0.6% |
| Cardiovascular Disorder |
0.6% |
|
| Cerebrovascular Accident |
8.6% |
| Rash |
8.6% |
| Gastrointestinal Haemorrhage |
8.0% |
| Haemorrhage |
7.1% |
| Haematuria |
6.2% |
| Nausea |
5.6% |
| Pruritus |
5.6% |
| Headache |
5.3% |
| Dizziness |
5.0% |
| Epistaxis |
5.0% |
| Adverse Event |
4.4% |
| Diarrhoea |
4.1% |
| Drug Dose Omission |
3.8% |
| Rectal Haemorrhage |
3.8% |
| Pulmonary Embolism |
3.5% |
| Somnolence |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Wrong Technique In Drug Usage Process |
2.9% |
| Circumstance Or Information Capable Of Leading To Medication Error |
2.7% |
| Death |
2.7% |
|
| Secondary |
| Atrial Fibrillation |
23.1% |
| Product Used For Unknown Indication |
19.0% |
| Cerebrovascular Accident Prophylaxis |
7.5% |
| Hypertension |
7.5% |
| Thrombosis |
5.4% |
| Thrombosis Prophylaxis |
5.4% |
| Transient Ischaemic Attack |
5.4% |
| Cerebrovascular Accident |
4.8% |
| Atrial Flutter |
2.7% |
| Deep Vein Thrombosis |
2.7% |
| Pain |
2.7% |
| Hip Arthroplasty |
2.0% |
| Ischaemic Cardiomyopathy |
2.0% |
| Blood Pressure |
1.4% |
| Blood Viscosity Increased |
1.4% |
| Cardiac Failure |
1.4% |
| Gastric Ulcer |
1.4% |
| Knee Arthroplasty |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Pulmonary Embolism |
1.4% |
|
| Renal Failure Acute |
8.6% |
| Cerebral Infarction |
5.7% |
| Contusion |
5.7% |
| Diarrhoea |
5.7% |
| Haematuria |
5.7% |
| Myalgia |
5.7% |
| Postoperative Wound Infection |
5.7% |
| Shock |
5.7% |
| Skin Reaction |
5.7% |
| Thrombocytopenia |
5.7% |
| Transaminases Increased |
5.7% |
| Transient Ischaemic Attack |
5.7% |
| Wound |
5.7% |
| Wrong Technique In Drug Usage Process |
5.7% |
| Angioedema |
2.9% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Blood Creatinine Increased |
2.9% |
| Cardioversion |
2.9% |
| Chronic Pigmented Purpura |
2.9% |
| Drug Dose Omission |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.1% |
| Atrial Fibrillation |
18.8% |
| Hypertension |
5.8% |
| Anaesthesia |
4.3% |
| Cerebrovascular Accident Prophylaxis |
4.3% |
| Arthritis |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Diabetes Mellitus |
2.9% |
| Vitamin D Deficiency |
2.9% |
| Anticoagulant Therapy |
1.4% |
| Anxiety |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Cardiac Disorder |
1.4% |
| Constipation Prophylaxis |
1.4% |
| Depression |
1.4% |
| Diabetic Retinal Oedema |
1.4% |
| Diabetic Retinopathy |
1.4% |
| Dyspepsia |
1.4% |
| Eye Haemorrhage |
1.4% |
| Local Swelling |
1.4% |
|
| Cerebrovascular Accident |
5.0% |
| Drug Ineffective |
5.0% |
| Hemiparesis |
5.0% |
| Incorrect Drug Administration Duration |
5.0% |
| Increased Upper Airway Secretion |
5.0% |
| Local Swelling |
5.0% |
| Mass |
5.0% |
| Nausea |
5.0% |
| Oropharyngeal Pain |
5.0% |
| Pain In Extremity |
5.0% |
| Photophobia |
5.0% |
| Pruritus |
5.0% |
| Pulmonary Hypertension |
5.0% |
| Rectal Haemorrhage |
5.0% |
| Suicidal Ideation |
5.0% |
| Transient Ischaemic Attack |
5.0% |
| Treatment Noncompliance |
5.0% |
| Tremor |
5.0% |
| Unevaluable Event |
5.0% |
| Urinary Tract Infection |
5.0% |
|
| Interacting |
| Asthma |
37.5% |
| Thrombosis Prophylaxis |
25.0% |
| Gastrooesophageal Reflux Disease |
12.5% |
| Hypertension |
12.5% |
| Hypothyroidism |
12.5% |
|
| Drug Interaction |
25.0% |
| Pneumonia |
25.0% |
| Rectal Haemorrhage |
25.0% |
| Subdural Haemorrhage |
25.0% |
|
